Emmanuel GYAN

Has grant

Professor of Hematology

Université de Tours Faculté de Médecine

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Emmanuel GYAN is a Professor of Hematology at Faculté de Médecine de Tours in France. His research focuses on various aspects of hematology, including chronic lymphocytic leukemia, acute myeloid leukemia, and the evaluation of immunomodulatory therapies in lymphoma. Recent publications have explored the mutation responses to Bruton Tyrosine Kinase inhibitors and the pharmacokinetic profiles of daunorubicin in acute myeloid leukemia patients.

Recent Grants

Grant: Close

Pilot study of the efficacy and tolerance of the adjunction of a Fish oil emulsion to daunorubicin and cytarabine chemotherapy for the treatment of Acute MYeloblastic Leukemia of Younger patients (under 61 years) with high-risk cytogenetics

Open Date: 2013-11-01

Close Date: 2015-12-01

Grant: Close

Open Date: 2013-01-01

Close Date: 2016-01-01

Grant: Close

BRIEF: Bendamustine and Rituximab In Elderly Follicular

Open Date: 2011-01-01

Close Date: 2013-01-01

Grant: Close

BRIEF: Bendamustine and Rituximab in Elderly Follicular

Open Date: 2011-01-01

Close Date: 2013-01-01

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Marie Briet

Professor

Université d'Angers

FRANCE

View details

Jordi Esteve Reyner

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

SPAIN

View details

Fabrice Gouilleux

CNRS Délégation Centre Poitou-Charentes

FRANCE

View details

Nicolas VALLET

Assistant Professor

Université de Tours Faculté de Médecine

FRANCE

View details

Noémie Ravalet

Université de Tours

FRANCE

View details

François CHAUMIER

MD, PhD, Head of Department

FRANCE

View details

Marine Baron

FRANCE

View details

Benoit Tessoulin

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Emmanuel GYAN

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (11)

A phase 1, first‐in‐human, dose‐escalation study of JNJ‐74856665 (dihydroorotate dehydrogenase inhibitor) alone or in combination in patients with AML or MDS

Heterogeneity of professional goals among residents enrolled in a palliative care track: results of a national online survey in France

NOTCH1 Mutation Is Associated With Response to Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: A Retrospective Study

Aberrant antioxidant responses in B‐cell non‐Hodgkin lymphoma

Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group

Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial

No survival improvement in patients with high‐risk multiple myeloma harbouring del(17p) and/or t(4;14) over the two past decades

Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer

Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial

Horizontal meta-analysis identifies common deregulated genes across AML subgroups providing a robust prognostic signature

Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma

Collaborators (8)

Marie Briet

Jordi Esteve Reyner

Fabrice Gouilleux

Nicolas VALLET

Noémie Ravalet

François CHAUMIER

Marine Baron

Benoit Tessoulin

Make your next move.